"The story lists the costs for screening – ""urine and blood tests that cost less than $25."" The story mentions some interventions for people with declining kidney function, but these are not quantified. We are also not told if screening and subsequent monitoring and pharmacological interventions save lives, or how many people would need to be screened in order to makes such programs or practices cost effective. The story focuses on the benefits of detecting disease. They could have talked about the potential harms of mass screening (i.e. the need to draw blood or the possibility of false positives). While the story is not focused on blood pressure management, per se, we are told that ACE (angiotensin II receptor blockers) inhibitors are ""good for the heart"", but the story does not mention potential side effects of these medications. The story does an adequate job of explaining the evidence. The story does not engage in disease mongering but some of the language used is questionable. The story says chronic kidney disease (CKD)  patients are ""terrified"" of having to go on dialysis, but no CKD patients are actually interviewed. The story does give an explanation of how kidney function works and how it can become impaired by heart disease, but to say the kidneys ""disintegrate"" with CKD is not accurate. The story only provides one perspective, that of the study author whose work is highlighted in the story. Interviews with primary care doctors and nephrologists, and possibly patients would be useful for balance and for discussion of the pros and cons of mass screening. The story provides treatment options (medication) for managing early-stage chronic kidney disease and options for people who are making the decision for renal replacement if chronic kidney disease progresses to end-stage kidney disease (dialysis and transplant). It’s fairly clear from the story that the screening tests for kidney disease that are discussed are generally already available, although perhaps not used as much as some think they should be. The story does not talk about the lack of any national guidelines for screening. That might have helped emphasize the novelty of developing a population-based screening approach. Early screening may help doctors and patients stave off some of the effects of cardiovascular disease with medications to reduce blood pressure. Information in this story does not appear to be taken from a press release."
Kidney, Heart Disease Spur Each Other